Risk Doesn't Escalate Overnight. It accumulates quietly between encounters.
Clinical trials prove efficacy.
They don't reveal what happens between prescription and outcome.
Between prescription and outcome lies uncertainty.
ONEai introduces Continuous Care Intelligence — infrastructure that transforms longitudinal patient-generated signals into structured, closed-loop insight across real-world care environments.
This is not passive data aggregation. It is measurable therapeutic accountability.
Longitudinal Intelligence
From retrospective review to Near-real-time trajectory.
Most real-world evidence platforms rely on claims and episodic documentation.
captures higher-frequency PGHD and PRO signals over time — revealing:
Adherence decay before decompensation
Symptom burden escalation
Beneficial decline before discontinuation
Engagement drop before abandonment
Instead of retrospective interpretation, pharma gains visibility into risk in motion.
This is trajectory intelligence, not static reporting.
Closed-Loop Action
Signal without action changes nothing.
ONEai converts predictive insight into structured next-best actions delivered to the appropriate stakeholder — physician, nurse, care manager, or patient — with documented workflow tracking.
Every intervention is:
Routed
Confirmed
Documented
Outcome-labeled
This produces verified cause-and-effect data — strengthening evidence generation and supporting payer dialogue.